tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Nanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
Company AnnouncementsNanobiotix SA’s Positive Earnings Call Highlights Strategic Growth
13h ago
Nanobiotix price target lowered to $8 from $12 at Guggenheim
PremiumThe Fly
Nanobiotix price target lowered to $8 from $12 at Guggenheim
1d ago
NBTX
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
PremiumRatings
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
1d ago
NBTX
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
PremiumRatings
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
2d ago
NBTX
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
PremiumRatings
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
5d ago
NBTX
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
PremiumRatingsNanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
15d ago
NBTX
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
Premium
Ratings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
17d ago
NBTX
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
Premium
Ratings
Strategic Licensing Amendment with Janssen Bolsters Nanobiotix’s Financial Outlook and Justifies Buy Rating
18d ago
NBTX
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
PremiumThe Fly
Nanobiotix amends global licensing agreement with Janssen Pharmaceutica
19d ago
JNJ
NBTX
Nanobiotix files $200M mixed securities shelf
PremiumThe Fly
Nanobiotix files $200M mixed securities shelf
30d ago
NBTX
Nanobiotix files to sell 5.62M ordinary shares for holders
PremiumThe Fly
Nanobiotix files to sell 5.62M ordinary shares for holders
30d ago
NBTX
Nanobiotix downgraded to Neutral from Buy at UBS
PremiumThe Fly
Nanobiotix downgraded to Neutral from Buy at UBS
2M ago
NBTX
Nanobiotix doses first patient in CONVERGE study
PremiumThe FlyNanobiotix doses first patient in CONVERGE study
2M ago
JNJ
NBTX
Nanobiotix completes dose escalation-expansion parts of NBTXR3 in PC
Premium
The Fly
Nanobiotix completes dose escalation-expansion parts of NBTXR3 in PC
4M ago
NBTX
Nanobiotix initiated with a Buy at Guggenheim
Premium
The Fly
Nanobiotix initiated with a Buy at Guggenheim
7M ago
NBTX
Nanobiotix initiated with a Buy at Guggenheim
PremiumThe Fly
Nanobiotix initiated with a Buy at Guggenheim
7M ago
NBTX
Nanobiotix initiated with a Buy at Stifel
PremiumThe Fly
Nanobiotix initiated with a Buy at Stifel
9M ago
NBTX
Nanobiotix announces new data from Study 1100
PremiumThe Fly
Nanobiotix announces new data from Study 1100
10M ago
NBTX
Nanobiotix provides update on NBTXR3 collaboration
PremiumThe Fly
Nanobiotix provides update on NBTXR3 collaboration
11M ago
JNJ
NBTX
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
PremiumThe FlyNanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
11M ago
JNJ
NBTX
Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study
Premium
The Fly
Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study
1y ago
NBTX
Nanobiotixachieves $20M milestone payment from Johnson & Johnson subsidiary
Premium
The Fly
Nanobiotixachieves $20M milestone payment from Johnson & Johnson subsidiary
1y ago
JNJ
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >